Autologous bone marrow mesenchymal stromal cell therapy for “no-option” critical limb ischemia is limited by karyotype abnormalities von Mohamed, Sara Azhari, Howard, Linda, McInerney, Veronica, Hayat, Amjad, Krawczyk, Janusz, Naughton, Sean, Finnerty, Andrew, Holohan, Miriam, Duffy, Aoife, Moloney, Tony, Kavanagh, Eamon, Burke, Paul, Liew, Aaron, Tubassam, Muhammad, Walsh, Stewart Redmond, O'Brien, Timothy

Volltext

Marrow changes and reduced proliferative capacity of mesenchymal stromal cells from patients with “no-option” critical limb ischemia; observations on feasibility of the autologous... von Mohamed, Sara Azhari, Duffy, Aoife, McInerney, Veronica, Krawczyk, Janusz, Hayat, Amjad, Naughton, Sean, Finnerty, Andrew, Holohan, Miriam, Liew, Aaron, Tubassam, Muhammad, Walsh, Stewart Redmond, O'Brien, Timothy, Howard, Linda

Volltext

Safety and Preliminary Efficacy of Mesenchymal Stromal Cell (ORBCEL-M) Therapy in Diabetic Kidney Disease: A Randomized Clinical Trial (NEPHSTROM) von Perico, Norberto, Remuzzi, Giuseppe, Griffin, Matthew D, Cockwell, Paul, Maxwell, Alexander P, Casiraghi, Federica, Rubis, Nadia, Peracchi, Tobia, Villa, Alessandro, Todeschini, Marta, Carrara, Fabiola, Magee, Bernadette A, Ruggenenti, Piero L, Rota, Stefano, Cappelletti, Laura, McInerney, Veronica, Griffin, Tomás P, Islam, Md Nahidul, Introna, Martino, Pedrini, Olga, Golay, Josée, Finnerty, Andrew A, Smythe, Jon, Fibbe, Willem E, Elliman, Stephen J, O'Brien, Timothy

Volltext